Changeflow GovPing Pharma & Drug Safety Carboxyalkyl Chitosan Patent Application
Routine Notice Added Final

Carboxyalkyl Chitosan Patent Application

Email

Summary

The USPTO has published a patent application (US20260078203A1) for a carboxyalkyl chitosan. The application details compositions, manufacturing processes, and therapeutic applications in areas such as rheumatology, ophthalmology, and dermatology. The filing date was November 26, 2025.

What changed

This document is a published patent application from the USPTO concerning a carboxyalkyl chitosan. The application, identified as US20260078203A1, details the composition, manufacturing process, and potential therapeutic applications of the substance. These applications span various medical and cosmetic fields, including rheumatology, ophthalmology, aesthetic medicine, plastic surgery, dermatology, and cosmetics.

As this is a patent application, it does not impose direct compliance obligations on regulated entities. However, it may be of interest to pharmaceutical and medical device companies involved in research and development within these therapeutic areas. The filing date for this application was November 26, 2025.

Source document (simplified)

← USPTO Patent Applications

Carboxyalkyl Chitosan

Application US20260078203A1 Kind: A1 Mar 19, 2026

Inventors

Mickaël Chausson, Pierre Douette, Sandrine Emilia Gautier, Philippe Vaesen, Houtaï Choumane, Guillermo Rocasalbas

Abstract

The present invention relates to a carboxyalkyl chitosan, compositions comprising same, a process for manufacturing same, and various applications thereof, in particular in the field of therapy, rheumatology, ophthalmology, aesthetic medicine, plastic surgery, internal surgery, dermatology or cosmetics.

CPC Classifications

C08B 37/003 A61K 9/0019 A61K 31/722 A61L 27/20 A61P 19/02 A61L 2400/06 A61L 2430/06

Filing Date

2025-11-26

Application No.

19402291

View original document →

Named provisions

Abstract

Classification

Agency
USPTO
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260078203A1

Who this affects

Applies to
Drug manufacturers Medical device makers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Therapeutic Applications Drug Development
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
R&D
Compliance frameworks
GxP
Topics
Medical Devices Cosmetics

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Therapeutics (A61P) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.